Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Seoul National University Hospital Partners With Quintiles On Clinical Trials

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Seoul National University Hospital, which is at the forefront of the government's drive to make South Korea a hub for global clinical trials, has signed a strategic alliance agreement to take part in Quintiles' Prime Site program

You may also be interested in...



Quintiles Enters Malaysia Clinical Trial Alliance For First Prime Site In Asia

SINGAPORE - Quintiles has entered an alliance with the University Malaya Medical Centre, creating its first clinical trial Prime Site in Asia, which is focused on accelerating drug development

As Korea Steps Up Drive To Attract Global Clinical Trials, American CRO Opens Outpost In Seoul

SEOUL - PRA International, a clinical research organization headquartered in Raleigh, N.C., recently opened its first office in Seoul as part of an expansion across Asia

South Korea Beefs Up Infrastructure To Lead Asia In Early-Stage Clinical Trials

SEOUL - South Korea is drawing more Phase I and Phase II clinical trials from its former foothold in Phase III and post-approval trials, Korea National Enterprise for Clinical Trials reported

Latest Headlines
See All
UsernamePublicRestriction

Register

SC073477

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel